The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users

Psychopharmacology

Volumn 231, Issue 4, 2014, Pages 707-716

  Young, Simon N ^a   Regoli, Martine ^a   Leyton, Marco ^a   Pihl, Robert O ^a   Benkelfat, Chawki ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

3,4 methylenedioxy N methylamphetamine; Ecstasy; Impulsivity; Mood; Serotonin; Tryptophan depletion

Indexed keywords

AFFECT; AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; SEROTONIN AGENTS; SEX FACTORS; TIME FACTORS; TRYPTOPHAN; YOUNG ADULT;

EID: 84893950048     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3287-2     Document Type: Article

References (68)

1. Allott K, Redman J (2007) Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)? Neurosci Biobehav Rev 31:327-347
2. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
3. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687-697
4. Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355-366
5. Berggren U, Eriksson M, Fahlke C, Balldin J (2002) Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission. Drug Alcohol Depend 65:159-165
6. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
7. Bond AJ, Verheyden SL, Wingrove J, Curran HV (2004) Angry cognitive bias, trait aggression and impulsivity in substance users. Psychopharmacology (Berl) 171:331-339
8. Buchert R, Thomasius R, Petersen K, Wilke F, Obrocki J, Nebeling B, Wartberg L, Zapletalova P, Clausen M (2006) Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users. Eur J Nucl Med Mol Imaging 33:188-199
9. Carhart-Harris R, Nutt D, Munafo M, Christmas D, Wilson S (2009) Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology (Berl) 206:187-196
10. Carpenter LL, Anderson GM, Pelton GH, Gudin JA, Kirwin PDS, Price LH, Heninger GR, McDougle CJ (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26-35
11. Cleare AJ, Bond AJ (1995) The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology (Berl) 118:72-81
12. Crockett MJ, Clark L, Roiser JP, Robinson OJ, Cools R, Chase HW, den Ouden H, Apergis-Schoute A, Campbell-Meikeljohn D, Seymour B, Sahakian BJ, Rogers RD, Robbins TW (2012) Converging evidence for central 5-HT effects in acute tryptophan depletion. Mol Psychiatry 17:121-123
13. Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology (Berl) 169:91-103
14. Daumann J, Pelz S, Becker SB, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001) Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol 16:627-633
15. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E (2004) Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology (Berl) 173:398-404
16. de Win MML, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W (2006) Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol (Oxf) 20:226-235
17. de Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W (2008) Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131:2936-2945
18. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418
19. First MB, Spitzer RL, Williams JBW, Gibbon M (1995) Structured clinical interview for DSM-IV: patient edition (SCID-P). ASP Press, Washington, DC
20. Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F (2001) Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("ecstasy") use history: psychobiological correlates. J Subst Abuse 13:471-491
21. Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology (Berl) 119:247-260
22. Halpern JH, Pope HG Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D (2004) Residual neuropsychological effects of illicit 3,4- methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75:135-147
23. Helmers KF, Young SN, Pihl RO (1995) Assessment of impulsivity in healthy male volunteers. Pers Individ Dif 19:927-935
24. Hoshi R, Pratt H, Mehta S, Bond AJ, Curran HV (2006) An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences? J Psychopharmacol (Oxf) 20:291-301
25. Huizink AC, Ferdinand RF, van der Ende J, Verhulst FC (2006) Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study. BMJ 332:825-828
26. Johnston LD, O'Malley PM, Bachman JG (2002) Monitoring the future: national survey results on drug use, 1975-2001. Volume II: college students and adult ages 19-40 (NIH Publication No. 02-5107). National Institute on Drug Abuse, Bethesda
27. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2011) Monitoring the future: national survey results on drug use, 1975-2010: volume II, college students and adults ages 19-50. Institute for Social Research, The University of Michigan, Ann Arbor
28. Johnston L, O'Malley P, Bachman J, Schulenberg JE (2012) Monitoring the future: national results on adolescent drug use: overview of key findings, 2011. Institute for Social Research, The University of Michigan, Ann Arbor
29. Kalasinsky KS, Hugel J, Kish SJ (2004) Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). J Forensic Sci 49:1106-1112
30. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602
31. Lamers CTJ, Bechara A, Rizzo M, Ramaekers JG (2006) Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol (Oxf) 20:302-311
32. LeMarquand DG, Pihl RO, Young SN, Tremblay RE, Séguin JR, Palmour RM, Benkelfat C (1998) Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology 19:333-341
33. LeMarquand DG, Benkelfat C, Pihl RO, Palmour RM, Young SN (1999) Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry 156:1771-1779
34. Lieb R, Schuetz CG, Pfister H, von Sydow K, Wittchen H (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68:195-207
35. Lorr M, McNair DM, Fisher S (1982) Evidence for bipolar mood states. J Pers Assess 46:432-436
36. McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"): a controlled study in humans. Neuropsychopharmacology 10:129-138
37. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437
38. McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA (1999a) Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxyamphetamine (MDMA) users. Psychopharmacology (Berl) 147:56-65
39. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999b) Cognitive performance in (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl) 143:417-425
40. McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology (Berl) 173:434-439
41. McNair DM, Lorr M, Droppleman LF (1988) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
42. Moja EA, Restani P, Corsini E, Stacchezzini MC, Assereto R, Galli CL (1991) Cycloheximide blocks the fall of plasma and tissue tryptophan levels after tryptophan-free amino acid mixtures. Life Sci 49:1121-1128
43. Moore P, Landolt HP, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, Gillin JC (2000) Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 23:601-622
44. Moreno FA, Heninger GR, McGahuey CA, Delgado PL (2000) Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes. Biol Psychiatry 48:327-329
45. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 31:1562-1573
46. Neumeister A, Habeler A, Praschak-Rieder N, Willeit M, Kasper S (1999) Tryptophan depletion: a predictor of future depressive episodes in seasonal affective disorder? Int Clin Psychopharmacol 14:313-315
47. Newman JP (1987) Reaction to punishment in extraverts and psychopaths: Implications for the impulsive behavior of disinhibited individuals. J Res Pers 21:464-480
48. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94:5308-5313
49. Parrott AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl) 173:234-241
50. Passamonti L, Crockett MJ, Apergis-Schoute AM, Clark L, Rowe JB, Calder AJ, Robbins TW (2012) Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression. Biol Psychiatry 71:36-43
51. Pihl RO, Young SN, Harden P, Plotnick S, Chamberlain B, Ervin FR (1995) Acute effect of altered tryptophan levels and alcohol on aggression in normal human males. Psychopharmacology (Berl) 119:353-360
52. Quednow B, Kühn K-U, Hoppe C, Westheide J, Maier W, Daum I, Wagner M (2007) Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("ecstasy"). Psychopharmacology (Berl) 189:517-530
53. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864-1869
54. Reneman L, de Win MML, van den Brink W, Booij J, den Heeten GJ (2006) Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol (Oxf) 20:164-175
55. Ricaurte GA, Yuan J, McCann UD (2000) (±)3,4- methylenedioxymethamphetamine ('ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10
56. Robinson O, Sahakian B (2009) Acute tryptophan depletion evokes negative mood in healthy females who have previously experienced concurrent negative mood and tryptophan depletion. Psychopharmacology (Berl) 205:227-235
57. Roiser JP, Rogers RD, Sahakian BJ (2007) Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology (Berl) 189:505-516
58. Ruhe HG, Mason NS, Schene AH (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12:331-359
59. Schilt T, Koeter M, Smal J, Gouwetor M, van den Brink W, Schmand B (2010) Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. Psychopharmacology (Berl) 207:583-591
60. Soar K, Turner JJD, Parrott AC (2001) Psychiatric disorders in ecstasy (MDMA) users: a literature review focussing on personal predisposition and drug history. Hum Psychopharmacology 16:641-645
61. Taffe MA, Huitrón-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH (2003) MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. Pharmacol Biochem Behav 76:141-152
62. Taylor SP (1967) Aggressive behavior and physiological arousal as a function of provocation and the tendency to inhibit aggression. J Pers 35:297-310
63. Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol (Oxf) 20:211-225
64. van Donkelaar EL, Blokland A, Ferrington L, Kelly PAT, Steinbusch HWM, Prickaerts J (2011) Mechanism of acute tryptophan depletion: is it only serotonin? Mol Psychiatry 16:695-713
65. Verheyden SL, Hadfield J, Calin T, Curran HV (2002) Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology (Berl) 161:23-31
66. Young SN, Leyton M (2002) The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav 71:857-865
67. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) 87:173-177
68. Zimmermann M, Grabemann M, Mette C, Abdel-Hamid M, Ueckermann J, Kraemer M, Wiltfang J, Kis B, Zepf FD (2012) The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit/hyperactivity disorder (ADHD) and healthy controls. PLoS ONE 7:e32023